title: Glycosylation sites selectively interfere with alpha-toxin binding to the nicotinic acetylcholine receptor.
abstract: Sequence analysis reveals unique features in the alpha-subunit of nicotinic acetylcholine receptors from the alpha-toxin-resistant cobra and mongoose. Included are N-linked glycosylation signals just amino-terminal to the Tyr190, Cys192-Cys193 region of the ligand binding domain, substitution of Trp187 and Phe189 by non-aromatic residues and alteration of the proline sequence Pro194-X-X-Pro197. Glycosylation signals were inserted into the toxin-sensitive mouse alpha-subunit by the mutations F189N and W187N/F189T. The F189N alpha-subunit, when transfected with beta, gamma and delta, showed a 140-fold loss of alpha-bungarotoxin affinity, whereas the W187N/F189T double mutation exhibited a divergence in alpha-toxin affinities at the two sites, one class showing a 600-fold and the other showing an 11-fold reduction. The W187N mutant and the double mutant F189N/S191A lacking the requisite glycosylation signals exhibited little alteration in affinity, as did the P194L and P197H mutations. The glycosylation sites had little or no influence on binding of toxins of intermediate (alpha-conotoxin, 1500 Da) or small mass (lophotoxin, 500 Da) and of the agonist, carbamylcholine. The two sites for the binding of alpha-conotoxin M1 have widely divergent dissociation constants of 2.1 and 14,800 nM. Expression of alpha/gamma- and alpha/delta-subunit pairs indicated that the high and low affinity sites are formed by the alpha/delta and alpha/gamma contacts, respectively.
authors.affiliation: Department of Pharmacology, University of California, San Diego, La Jolla 92093.
authors.forename: H J
authors.initials: HJ
authors.lastname: Kreienkamp
authors.forename: S M
authors.initials: SM
authors.lastname: Sine
authors.forename: R K
authors.initials: RK
authors.lastname: Maeda
authors.forename: P
authors.initials: P
authors.lastname: Taylor
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D002038:Bungarotoxins / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D002460:Cell Line; D003064:Cnidarian Venoms / Q000494:pharmacology; D018076:DNA, Complementary / Q000378:metabolism; D017815:Elapidae; D006031:Glycosylation; D008988:Herpestidae; D006801:Humans; D007668:Kidney; D007700:Kinetics; D051379:Mice; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D011978:Receptors, Nicotinic / Q000096:biosynthesis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D013729:Terpenes; D010738:Type C Phospholipases / Q000378:metabolism*
chemical_list: D002038:Bungarotoxins; D003064:Cnidarian Venoms; D018076:DNA, Complementary; D011978:Receptors, Nicotinic; D011994:Recombinant Proteins; D013729:Terpenes; C030303:lophotoxin; D002217:Carbachol; D010738:Type C Phospholipases